Except that your second point under "New Good News" needs to be heavily caveat-ed, I feel.
Because it doesn't go far enough to addressing potential capital shortfalls under certain (quite realistic) scenarios, I think the market's concerns about the stock will linger, thereby preventing any re-rating.
I think they should have bitten the bullet and raised $250m.
That would have placated the market.
But even after this issuance, they will still be a bit half pregnant.
EHE Price at posting:
$2.45 Sentiment: None Disclosure: Not Held